Free Trial

Achmea Investment Management B.V. Acquires 19,386 Shares of Cigna Group (NYSE:CI)

Cigna Group logo with Medical background

Achmea Investment Management B.V. grew its position in shares of Cigna Group (NYSE:CI - Free Report) by 20.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 112,043 shares of the health services provider's stock after buying an additional 19,386 shares during the quarter. Achmea Investment Management B.V.'s holdings in Cigna Group were worth $36,862,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in CI. TCTC Holdings LLC bought a new stake in Cigna Group during the fourth quarter valued at about $25,000. Putney Financial Group LLC bought a new position in shares of Cigna Group during the 4th quarter valued at approximately $36,000. Transce3nd LLC purchased a new stake in Cigna Group in the 4th quarter worth approximately $38,000. Ameriflex Group Inc. purchased a new stake in Cigna Group in the 4th quarter worth approximately $44,000. Finally, Heck Capital Advisors LLC purchased a new position in Cigna Group during the fourth quarter valued at approximately $53,000. 86.99% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently weighed in on CI shares. Cowen restated a "buy" rating on shares of Cigna Group in a research note on Monday, May 5th. Cantor Fitzgerald boosted their price objective on Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a research report on Thursday, March 20th. Morgan Stanley upped their price objective on Cigna Group from $379.00 to $390.00 and gave the stock an "overweight" rating in a research note on Monday, May 5th. Wall Street Zen raised Cigna Group from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, April 8th. Finally, Robert W. Baird dropped their price target on Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Two analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have assigned a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $380.39.

Check Out Our Latest Analysis on CI

Cigna Group Stock Performance

NYSE CI opened at $328.66 on Friday. The business's 50 day moving average price is $320.71 and its 200-day moving average price is $307.71. Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The company has a market cap of $87.80 billion, a P/E ratio of 18.20, a P/E/G ratio of 0.94 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.72 and a current ratio of 0.72.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping the consensus estimate of $6.35 by $0.39. The company had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. Cigna Group's quarterly revenue was up 14.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.47 earnings per share. Sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd were paid a dividend of $1.51 per share. The ex-dividend date of this dividend was Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.84%. Cigna Group's dividend payout ratio is 33.44%.

Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double
The Next Palantir? AI-Defense Stock Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines